Brown, Lisle/Cummings’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Brown, Lisle/Cummings's ZBH Position: Q2 2026 in Review
Brown, Lisle/Cummings reduced its Zimmer Biomet (ZBH) stake by 49% in Q2 2026, selling an estimated $74.9K and leaving 905 shares worth $77.9K. The position accounts for 0.02% of the portfolio, ranked #330.
Brown, Lisle/Cummings first reported a position in ZBH in Q4 2021 and has held it in 19 quarters since. The position peaked at $382K in Q2 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Brown, Lisle/Cummings held 905 shares of Zimmer Biomet worth $77.9K as of Q2 2026.
- Brown, Lisle/Cummings sold 854 Zimmer Biomet shares in Q2 2026, an estimated $74.9K.
- Zimmer Biomet made up 0.02% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #330 holding.
- Brown, Lisle/Cummings first reported a position in Zimmer Biomet in Q4 2021 and has held it in 19 quarters since.
- Brown, Lisle/Cummings's Zimmer Biomet position peaked at $382K in Q2 2023.
- 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.